Bryleos is a clinical-stage therapeutics company.
Bryleos has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in June 2023.
Bryleos's investors include Eddie Jordan.
Bryleos is headquartered in Johnson City, United States.
Bryleos is a clinical-stage therapeutics company.
Bryleos is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bryleos — Funding & Investors." VCBacked, June 13, 2023, https://www.vcbacked.co/company/bryleos. Accessed September 29, 2026.
VCBacked. (2023). Bryleos — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/bryleos
{{cite web |title=Bryleos — Funding & Investors |url=https://www.vcbacked.co/company/bryleos |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated